Research by Liu et al. found that upregulation of microRNA-200a in osteosarcoma led to PD-L1-induced suppression of CD8+ T cell function, highlighting its potential as an immunotherapy target (Liu et al., 2020). Here, CD8A is linked to osteosarcoma.